David Rinaldi
Publications by Year
Research Areas
Colorectal Cancer Treatments and Studies, Lung Cancer Treatments and Mutations, Cancer Treatment and Pharmacology, Lung Cancer Research Studies, Neutropenia and Cancer Infections
Most-Cited Works
- → Phase II trial of irinotecan in patients with progressive or rapidly recurrent colorectal cancer.(1996)352 cited
- → Phase III Comparison of Two Irinotecan Dosing Regimens in Second-Line Therapy of Metastatic Colorectal Cancer(2003)298 cited
- → Multicenter, Randomized Trial for Stage IIIB or IV Non–Small-Cell Lung Cancer Using Weekly Paclitaxel and Carboplatin Followed by Maintenance Weekly Paclitaxel or Observation(2003)205 cited
- → A phase I evaluation of multitargeted antifolate (MTA, LY231514), administered every 21 days, utilizing the modified continual reassessment method for dose escalation(1999)175 cited
- → Initial phase I evaluation of the novel thymidylate synthase inhibitor, LY231514, using the modified continual reassessment method for dose escalation.(1995)152 cited
- → Randomized, Phase III Study of Weekly Paclitaxel in Combination With Carboplatin Versus Standard Every-3-Weeks Administration of Carboplatin and Paclitaxel for Patients With Previously Untreated Advanced Non–Small-Cell Lung Cancer(2008)145 cited
- → Phase I and Pharmacokinetic Study of Temozolomide on a Daily-for-5-Days Schedule in Patients With Advanced Solid Malignancies(1999)133 cited
- → Preoperative Therapy with Concurrent Paclitaxel/Carboplatin/Infusional 5-FU and Radiation Therapy in Locoregional Esophageal Cancer(2003)104 cited
- → Peripheral neuropathy secondary to docetaxel (Taxotere)(1996)103 cited
- → A Bioavailability and Pharmacokinetic Study of Oral and Intravenous Hydroxyurea(1998)82 cited